Multi-Center, Randomized, Double-Blind, Placebo-Controlled With Open Label Run-in Study Assessing Efficacy, Tolerability, Safety of BTDS 10 or 20 Compared to Placebo in Opioid-naive Subjects With Moderate to Severe, Chronic Low Back Pain.

Trial Profile

Multi-Center, Randomized, Double-Blind, Placebo-Controlled With Open Label Run-in Study Assessing Efficacy, Tolerability, Safety of BTDS 10 or 20 Compared to Placebo in Opioid-naive Subjects With Moderate to Severe, Chronic Low Back Pain.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Dec 2011

At a glance

  • Drugs Buprenorphine (Primary)
  • Indications Back pain
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 01 Dec 2011 Results published in the Journal of Pain and Symptom Management.
    • 26 Oct 2011 Results published in the Journal of Pain and Symptom Management, and also in a Purdue Pharma media release.
    • 19 Nov 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top